Arcutis Biotherapeutics CFO John Smither receives $6.3M in 2021
Arcutis Biotherapeutics reports 2021 executive compensation
By ExecPay News
Published: April 19, 2022
Arcutis Biotherapeutics reported fiscal year 2021 executive compensation information on April 19, 2022.
In 2021, six executives at Arcutis Biotherapeutics received on average a compensation package of $3.3M, a 10% decrease compared to previous year.
Average pay of disclosed executives at Arcutis Biotherapeutics
John Smither, Chief Financial Officer, received $6.3M in total. 86% of Smither's compensation, or $5.4M, was in option awards. Smither also received $100K in salary, $755K in stock awards, as well as $11K in other compensation.
For fiscal year 2021, the median employee pay was $342,623 at Arcutis Biotherapeutics. Therefore, the ratio of John Smither's pay to the median employee pay was 18 to one.
Todd Franklin Watanabe, Chief Executive Officer, received a compensation package of $4.3M, which increased by 56% compared to previous year. 53% of the compensation package, or $2.3M, was in option awards.
Matthew Moore, Chief Business Officer, earned $3.8M in 2021.
Scott Burrows, Chief Financial Officer, received $2.1M in 2021.
Patrick E. Burnett, Chief Medical Officer, earned $1.7M in 2021, a 76% decrease compared to previous year.
David W. Osborne, Chief Technical Officer, received $1.6M in 2021.
Related executives
Todd Watanabe
Arcutis Biotherapeutics
Chief Executive Officer
Matthew Moore
Arcutis Biotherapeutics
Chief Business Officer
Scott Burrows
Arcutis Biotherapeutics
Chief Financial Officer
Patrick Burnett
Arcutis Biotherapeutics
Chief Medical Officer
David Osborne
Arcutis Biotherapeutics
Chief Technical Officer
John Smither
Arcutis Biotherapeutics
Chief Financial Officer
You may also like
Source: SEC filing on April 19, 2022.